Correo: bd@sidmexinovia.com
Teléfono: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Inicio >
Takfa 0.25 mg Capsule
Takfa 0.25 mg Capsule
Manufacturer/Marketed By : Intas Pharmaceuticals Ltd
$1.64 $1.24
Takfa 0.25 mg capsules are an essential immunosuppressive medication designed to help prevent organ rejection in patients who have undergone transplants, such as kidney, liver, or heart transplants. By intentionally...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Tacrolimus 0.25 mg
Active Pharmaceutical Ingredient
Takfa 0.25 mg Capsule
1,64 US$
1,24 US$
Takfa 0.25 mg capsules are an essential immunosuppressive medication designed to help prevent organ rejection in patients who have undergone transplants, such as kidney, liver, or heart transplants. By intentionally dampening the immune response, Takfa allows the body to better accept the newly transplanted organ, significantly lowering the likelihood of rejection. This medication is typically used alongside other immunosuppressive agents to create a comprehensive treatment plan for transplant recipients. While Takfa is effective in facilitating organ acceptance, it is crucial to monitor for potential side effects and to be aware of the increased risk of infections due to its immune-modulating properties. Patients should adhere strictly to their prescribed dosage and consult their healthcare provider if they experience any unusual symptoms. Always inform your doctor of any other medications or health conditions before starting Takfa to ensure a safe treatment experience. With proper use, Takfa 0.25 mg capsules play a vital role in improving the long-term success of organ transplantation.
Active Pharmaceutical Ingredient
Usos
• Takfa 0 25 mg capsule is primarily utilized in transplant medicine to prevent organ rejection. It plays a crucial role in managing the immune response of patients who have received an organ transplant. By suppressing the activity of immune cells, Takfa helps maintain the acceptance of the transplanted organ. This is essential for the long-term success of the transplant procedure.
• In addition to preventing organ rejection, Takfa 0 25 mg capsule is often prescribed to enhance the overall success of transplant surgeries. The immunosuppressive properties of Takfa are vital for patients who may be at higher risk of rejection due to their immune system's response. By carefully managing the immune system, Takfa aids in creating a more favorable environment for the transplanted organ. This contributes to improved patient outcomes and longevity of the transplant.
• Takfa 0 25 mg capsule can also be an important part of post-operative care for transplant recipients. After surgery, patients need to follow a strict regimen to ensure their body does not reject the new organ. Takfa assists in this process by reducing inflammation and immune activation that could compromise the transplant. This supportive role is vital for helping patients adapt to their new organ and recover effectively.
• Healthcare providers may recommend Takfa 0 25 mg capsule in combination with other immunosuppressants to optimize treatment plans for transplant patients. The use of Takfa in conjunction with other medications can provide a comprehensive approach to managing organ rejection risk. This combination therapy is tailored to each patient's needs, enhancing the likelihood of successful transplantation. Overall, Takfa serves as a key component in the arsenal against organ rejection.
Beneficios
Takfa 0.25 mg Capsule prevent the rejection of transplanted organs, such as the kidney, liver, and heart. It works by suppressing the immune system, which reduces the risk of the body rejecting the transplanted organ. Takfa Capsule may also be effective in treating certain autoimmune disorders, such as lupus, sarcoidosis, and myasthenia gravis. Takfa 0.25 mg is less likely to cause infections compared to other immunosuppressive drugs. Takfa 0.25 mg Capsule can be used in combination with other immunosuppressive medications, such as cyclosporine, to increase its effectiveness.
Efectos secundarios
Like all medication, Takfa 0.25 mg Capsule may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Efectos secundarios más comunes
• Pain around the transplanted kidney
• Pain or burning when you urinated
• Dark urine
• Yellowing of the skin or eyes
• Loss of muscle control
• Confusion
• Thinking problems
Efectos secundarios comunes
• Nausea
• Vomiting
• Stomach pain
• Headache
• Rash
• Fever
• Dizziness
• Sore Throat
• Cold
• Fast heart rate
• Low blood pressure
• Low blood glucose levels
• Diarrhoea
Cómo utilizar
Take Takfa 0.25 mg Capsule on an empty stomach, at least 1 hour before or 2 hours after eating. The exact dosage and duration of treatment will be determined by a doctor and will depend on the individual's condition and response to the medication. It's very important to take Takfa 0.25 mg exactly as prescribed by your doctor and not to change the dose or stop taking Takfa 0.25 Capsule without first consulting your doctor. It's also important to keep all appointments with your doctor and lab tests while taking this Takfa to check your progress and monitor for side effects.
Consejos de seguridad
• Alcohol: Drinking alcohol while taking Takfa 0.25 mg is not recommended. Alcohol may increase the risk of side effects or interfere with the effectiveness Takfa 0.25 mg Capsule. Before drinking alcohol while taking any medicine, it is best to talk to your doctor or pharmacist.
• Kidney: Patients with kidney disease should use Takfa 0.25 mg with caution. It is important that patients with kidney disease monitor their kidney function closely while taking Takfa Capsule and report any unusual symptoms or changes in kidney function to their doctor or health care professional. The dose of Takfa 0.25 mg Capsule may need to be adjusted in patients with kidney disease.
• Breastfeeding: Breastfeeding is not recommended while you are taking Takfa 0.25 Capsule. It is possible that Takfa Capsule may pass into breast milk and cause harm to the baby. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed if you are breastfeeding and taking Takfa. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Liver: Patients with liver disease should use Takfa 0.25 mg Capsule with caution. It is important that patients with liver disease monitor their liver function closely and report any unusual symptoms or changes to their doctor. The dose for Takfa 0.25 Capsule may require adjustment in patients with liver disease.
• Pregnancy: The use of Takfa 0.25 mg Capsule during pregnancy may not be safe as there is some evidence from animal studies that it may harm the developing foetus. It is important that you talk to your doctor about the potential risks and benefits of taking Takfa 0.25 mg while pregnant. Your doctor can help you make the best decision for you and your baby.
• Driving: Takfa 0.25 mg Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Takfa Capsule.
Descargo de responsabilidad
Sidmex Inovia se esfuerza por brindar información precisa y confiable; sin embargo, todo el contenido de este sitio web, incluidas las descripciones y composiciones de los productos, tiene fines meramente informativos y no debe considerarse un sustituto del consejo, diagnóstico o tratamiento médico profesional.
Se recomienda a los usuarios consultar con un profesional de la salud calificado antes de tomar cualquier decisión médica. La información proporcionada no debe utilizarse para el autodiagnóstico ni la automedicación.
Todos los productos listados están destinados exclusivamente a fines comerciales y consultas al por mayor. Sidmex Inovia no promueve el uso directo por parte del consumidor y su objetivo es apoyar, no reemplazar, la relación entre el profesional de la salud y el paciente.
Los nombres de productos, marcas registradas y marcas comerciales pertenecen a sus respectivos propietarios, y su uso no implica ninguna afiliación ni respaldo. Sidmex Inovia no se responsabiliza por las consecuencias derivadas del uso de la información proporcionada en este sitio web.